ARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activity. (Record no. 19837816)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01835 a2200529 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515223852.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201009s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1538-8514 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1158/1535-7163.MCT-09-1173 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Munshi, Neru |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20100916 |
245 00 - TITLE STATEMENT | |
Title | ARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activity. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Molecular cancer therapeutics |
Date of publication, distribution, etc. | Jun 2010 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1544-53 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Apoptosis |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Caspases |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line, Tumor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Proliferation |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunosuppression Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice, Nude |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasms |
General subdivision | enzymology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phosphorylation |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein Kinase Inhibitors |
General subdivision | chemistry |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proto-Oncogene Mas |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proto-Oncogene Proteins c-met |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrroles |
General subdivision | chemistry |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrrolidinones |
General subdivision | chemistry |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Quinolines |
General subdivision | chemistry |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Signal Transduction |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jeay, Sébastien |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Li, Youzhi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chen, Chang-Rung |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | France, Dennis S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ashwell, Mark A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hill, Jason |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Moussa, Magdi M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Leggett, David S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Li, Chiang J |
773 0# - HOST ITEM ENTRY | |
Title | Molecular cancer therapeutics |
Related parts | vol. 9 |
-- | no. 6 |
-- | p. 1544-53 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1158/1535-7163.MCT-09-1173">https://doi.org/10.1158/1535-7163.MCT-09-1173</a> |
Public note | Available from publisher's website |
No items available.